|
1
|
Liaw YF, Leung N, Kao JH, et al:
Asian-Pacific consensus statement on the management of chronic
hepatitis B: a 2008 update. Hepatol Int. 2:263–283. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sastrosoewignjo RI, Sandjaja B and Okamoto
H: Molecular epidemiology of hepatitis B virus in Indonesia. J
Gastroenterol Hepatol. 6:491–498. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Khan M, Dong JJ, Acharya SK, et al:
Hepatology issues in Asia: perspective from regional leaders. J
Gastroenterol Hepatol. 19:S419–S430. 2004. View Article : Google Scholar
|
|
4
|
Chu CM, Karayiannis P, Fowler MJ,
Monjardino J, Liaw YF and Thomas HC: Natural history of chronic
hepatitis B virus infection in Taiwan: studies of hepatitis B virus
DNA in serum. Hepatology. 5:431–434. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hadziyannis SJ and Vassilopoulos D:
Hepatitis B e antigen-negative chronic hepatitis B. Hepatology.
34:617–624. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lau JY and Wright TL: Molecular virology
and pathogenesis of hepatitis B. Lancet. 342:1335–1340.
1993.PubMed/NCBI
|
|
7
|
Davidson F, Lycett C, Sablon E, Petrik J
and Dow BC: Hepatitis B virus genotypes and precore mutations in
Scottish blood donors. Vox Sang. 88:87–92. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Locarnini S, McMillan J and Bartholomeusz
A: The hepatitis B virus and common mutants. Semin Liver Dis.
23:5–20. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Parekh S, Zoulim F, Ahn SH, et al: Genome
replication, virion secretion, and e antigen expression of
naturally occurring hepatitis B virus core promoter mutants. J
Virol. 77:6601–6612. 2003. View Article : Google Scholar
|
|
10
|
Okamoto H, Yotsumoto S, Akahane Y, et al:
Hepatitis B viruses with precore region defects prevail in
persistently infected hosts along with seroconversion to the
antibody against e antigen. J Virol. 64:1298–1303. 1990.
|
|
11
|
Kao JH: Hepatitis B viral genotypes:
clinical relevance and molecular characteristics. J Gastroenterol
Hepatol. 17:643–650. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lok AS, Akarca U and Greene S: Mutations
in the precore region of hepatitis B virus serve to enhance the
stability of the secondary structure of the pre-genome
encapsidation signal. Proc Natl Acad Sci USA. 91:4077–4081. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Rodriguez-Frias F, Buti M, Jardi R,
Cotrina M, Viladomiu L, Esteban R and Guardia J: Hepatitis B virus
infection: precore mutants and its relation to viral genotypes and
core mutations. Hepatology. 22:1641–1647. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Buckwold VE, Xu Z, Chen M, Yen TS and Ou
JH: Effects of a naturally occurring mutation in the hepatitis B
virus basal core promoter on precore gene expression and viral
replication. J Virol. 70:5845–5851. 1996.PubMed/NCBI
|
|
15
|
Hunt CM, McGill JM, Allen MI and Condreay
LD: Clinical relevance of hepatitis B virus mutations. Hepatology.
31:1037–1044. 2000. View Article : Google Scholar
|
|
16
|
Baumert TF, Rogers SA, Hasegawa K and
Liang TJ: Two core promoter mutations identified in a hepatitis B
virus strain associated with fulminant hepatitis result in enhanced
viral replication. J Clin Invest. 98:2268–2276. 1996. View Article : Google Scholar
|
|
17
|
Okamoto H, Tsuda F, Akahane Y, et al:
Hepatitis B virus with the mutations in the core promoter for an e
antigen-negative phenotype in carriers with antibody to e antigen.
J Virol. 68:8102–8110. 1994.PubMed/NCBI
|
|
18
|
Kidd-Ljunggren K, Oberg M and Kidd AH:
Hepatitis B virus X gene 1751 to 1764 mutations: implications for
HBeAg status and disease. J Gen Virol. 78:1469–1478.
1997.PubMed/NCBI
|
|
19
|
European Association for the Study of the
Liver (EASL): EASL clinical practice guidelines: management of
chronic hepatitis B. J Hepatol. 50:227–242. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hosono S, Tai PC, Wang W, et al: Core
antigen mutation of human hepatitis B virus in hepatomas accumulate
in MHC class II-restricted T cell epitopes. Virology. 212:151–162.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Okumura A, Ishikawa T, Yoshioka K, Yuasa
R, Fukuzawa Y and Kakumu S: Mutation at codon 130 in hepatitis B
virus (HBV) core region increases markedly during acute
exacerbation of hepatitis in chronic HBV carriers. J Gastroenterol.
36:103–110. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
World Health Organization: Hepatitis B.
2002, http://www.who.int/csr/disease/hepatitis/whocdscsrlyo20022/en/uri.
Accessed February 1, 2006.
|
|
23
|
Lusida MI, Surayah Sakugawa H, et al:
Genotype and subtype analyses of hepatitis B virus (HBV) and
possible co-infection of HBV and hepatitis C virus (HCV) or
hepatitis D virus (HDV) in blood donors, patients with chronic
liver disease and patients on hemodialysis in Surabaya, Indonesia.
Microbiol Immunol. 47:969–975. 2003. View Article : Google Scholar
|
|
24
|
Sugauchi F, Mizokami M, Orito E, et al: A
novel variant genotype C of hepatitis B virus identified in
isolates from Australian Aborigines: complete genome and
phylogenetic relatedness. J Gen Virol. 82:883–892. 2001.PubMed/NCBI
|
|
25
|
Lusida MI, Nugrahaputra VE, Soetjipto, et
al: Novel subgenotypes of hepatitis B virus genotypes C and D in
Papua, Indonesia. J Clin Microbiol. 46:2160–2166. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Magnius LO and Norder H: Subtypes,
genotypes and molecular epidemiology of the hepatitis B virus as
reflected by sequence variability of the S-gene. Intervirology.
38:24–34. 1995.PubMed/NCBI
|
|
27
|
Arauz-Ruiz P, Norder H, Visona KA and
Magnius LO: Molecular epidemiology of hepatitis B virus in Central
America reflected in the genetic variability of the small S gene. J
Infect Dis. 176:851–858. 1997. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liu Y, Zhong Y, Zou Z, et al: Features and
clinical implications of hepatitis B virus genotypes and mutations
in basal core promoter/precore region in 507 Chinese patients with
acute and chronic hepatitis B. J Clin Virol. 47:243–247. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Carman WF, Jacyna MR, Hadziyannis S,
Karayiannis P, McGarvey MJ, Makris A and Thomas HC: Mutation
preventing formation of hepatitis B e antigen in patients with
chronic hepatitis B infection. Lancet. 2:588–591. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Schlicht HJ and Schaller H: The secretory
core protein of human hepatitis B virus is expressed on the cell
surface. J Virol. 63:5399–5404. 1989.PubMed/NCBI
|
|
31
|
Chan HL, Hussain M and Lok AS: Different
hepatitis B virus genotypes are associated with different mutations
in the core promoter and precore regions during hepatitis B e
antigen sero-conversion. Hepatology. 29:976–984. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chisari FV: Perspectives series:
host/pathogen interactions. Cytotoxic T cells and viral hepatitis.
J Clin Invest. 99:1472–1477. 1997. View Article : Google Scholar
|
|
33
|
Friedt M, Gerner P, Lausch E, Trubel H,
Zabel B and Wirth S: Mutations in the basic core promoter and the
precore region of hepatitis B virus and their selection in children
with fulminant and chronic hepatitis B. Hepatology. 29:1252–1258.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kao JH, Chen PJ, Lai MY and Chen DS:
Clinical and virological aspects of blood donors infected with
hepatitis B virus genotypes B and C. J Clin Microbiol. 40:22–25.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lindh M, Anderson AS and Gusdal A:
Genotypes, nt 1858 variants, and geographic origin of hepatitis B
virus - large-scale analysis using a new genotyping method. J
Infect Dis. 175:1285–1293. 1997. View
Article : Google Scholar : PubMed/NCBI
|
|
36
|
Hadziyannis SJ: Hepatitis B e
antigen-negative chronic hepatitis B: from clinical recognition to
pathogenesis and treatment. Viral Hepat Rev. 1:7–36. 1995.
|
|
37
|
Kramvis A and Kew MC: Relationship of
genotypes of hepatitis B virus to mutations, disease progression
and response to antiviral therapy. J Viral Hepat. 12:456–464. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Mulyanto, Depamede SN, Surayah K, Tsuda F,
Ichiyama K, Takahashi M and Okamoto H: A nationwide molecular
epidemio-logical study on hepatitis B virus in Indonesia:
identification of two novel subgenotypes, B8 and C7. Arch Virol.
154:1047–1059. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zarski JP, Marcellin P, Cohard M, Lutz JM,
Bouche C and Rais A: Comparison of anti-HBe-positive and
HBe-antigen-positive chronic hepatitis B in France. Multicentre
Group. J Hepatol. 20:636–640. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Chan HL, Ghany MG and Lok ASF: Hepatitis
B. Schiff’s Diseases of the Liver. Schiff ER, Sorrell MF and
Maddrey WC: 1. 8th edition. Lippincott Williams and Wilkins;
Philadelphia: pp. 757–791. 1999
|
|
41
|
Günther S, Piwon N and Will H: Wild-type
levels of pregenomic RNA and replication but reduced pre-C RNA and
e-antigen synthesis of hepatitis B virus with C(1653)→T, A(1762)→T
and G(1764)→A mutations in the core promoter. J Gen Virol.
79:375–380. 1998.PubMed/NCBI
|
|
42
|
Kidd-Ljunggren K, Oberg M and Kidd AH: The
hepatitis B virus X gene: analysis of functional domain variation
and gene phylogeny using multiple sequences. J Gen Virol.
76:2119–2130. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Li J, Buckwold VE, Hon MW and Ou JH:
Mechanism of suppression of hepatitis B virus precore RNA
transcription by a frequent double mutation. J Virol. 73:1239–1244.
1999.PubMed/NCBI
|
|
44
|
Cho SW, Shin YJ, Hahm KB, Jin JH, Kim YS,
Kim JH and Kim HJ: Analysis of the precore and core promoter DNA
sequence in liver tissues from patients with hepatocellular
carcinoma. J Korean Med Sci. 14:424–430. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Bozkaya H, Ayola B and Lok AS: High rate
of mutations in the hepatitis B core gene during the immune
clearance phase of chronic hepatitis B virus infection. Hepatology.
24:32–37. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Pumpens P and Grens E: HBV core particles
as a carrier for B cell/T cell epitopes. Intervirology. 44:98–114.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Alexopoulou A, Baltayiannis G, Eroglu C,
Nastos T, Dourakis SP, Archimandritis AJ and Karayiannis P: Core
mutations in patients with acute episodes of chronic HBV infection
are associated with the emergence of new immune recognition sites
and the development of high IgM anti-HBc index values. J Med Virol.
81:34–41. 2009. View Article : Google Scholar
|
|
48
|
Hsu YS, Chien RN, Yeh CT, Sheen IS, Chiou
HY, Chu CM and Liaw YF: Long-term outcome after spontaneous HBeAg
sero-conversion in patients with chronic hepatitis B. Hepatology.
35:1522–1527. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Sallberg M, Ruden U, Wahren B, Noah M and
Magnius LO: Human and murine B cells recognize the HBeAg/beta (or
HBe2) epitope as a linear determinant. Mol Immunol. 28:719–726.
1991. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Milich DR, Peterson DL, Schodel F, Jones
JE and Hughes JL: Preferential recognition of hepatitis B
nucleocapsid antigens by Th1 or Th2 cells is epitope and major
histocompatibility complex dependent. J Virol. 69:2776–2785.
1995.PubMed/NCBI
|
|
51
|
Milich DR, Schodel F, Hughes JL, Jones JE
and Peterson DL: The hepatitis B virus core and e antigens elicit
different Th cell subsets: antigen structure can affect Th cell
phenotype. J Virol. 71:2192–2201. 1997.PubMed/NCBI
|
|
52
|
Yuan TT and Shih C: A frequent, naturally
occurring mutation (P130T) of human hepatitis B virus core antigen
is compensatory for immature secretion phenotype of another
frequent variant (I97L). J Virol. 74:4929–4932. 2000. View Article : Google Scholar
|
|
53
|
Kreutz C: Molecular, immunological and
clinical properties of mutated hepatitis B viruses. J Cell Mol Med.
6:113–143. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Yuan TT, Sahu GK, Whitehead WE, Greenberg
R and Shih C: The mechanism of an immature secretion phenotype of a
highly frequent naturally occurring missense mutation at codon 97
of human hepatitis B virus core antigen. J Virol. 73:5731–5740.
1999.
|
|
55
|
Yuan TT, Tai PC and Shih C:
Subtype-independent immature secretion and subtype-dependent
replication deficiency of a highly frequent, naturally occurring
mutation of human hepatitis B virus core antigen. J Virol.
73:10122–10128. 1999.
|
|
56
|
Lin CL and Kao JH: Hepatitis B viral
factors and clinical outcomes of chronic hepatitis B. J Biomed Sci.
15:137–145. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Hadziyannis SJ and Papatheodoridis GV:
Hepatitis B e antigen-negative chronic hepatitis B: natural history
and treatment. Semin Liver Dis. 26:130–141. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Lin CL, Liao LY, Liu CJ, et al: Hepatitis
viral factors in HBeAg-negative carriers with persistently normal
serum alanine aminotransferase levels. Hepatology. 45:1193–1198.
2007. View Article : Google Scholar
|
|
59
|
Abbas Z, Muzaffar R, Siddiqui A, Naqvi SA
and Rizvi SA: Genetic variability in the precore and core promoter
regions of hepatitis. B virus strains in Karachi. BMC
Gastroenterol. 6:202006. View Article : Google Scholar : PubMed/NCBI
|
